- Supported exchanges /
- F /
- 6HN.F
EVEREST MED.LTD DL-0001 (6HN F) stock market data APIs
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline includes Nefecon, an oral formulation of budesonide for the treatment of immunoglobulin nephropathy (IgAN); Xerava, a fully synthetic fluorocycline intravenous antibiotic for the treatment of infections caused by susceptible gram-positive, gram-negative, and anaerobic pathogens; Taniborbactam, a beta-lactamase inhibitor (BLI) which is in phase 3 clinical trial for the treatment of patients with serious bacterial infections; and Etrasimod, an oral selective sphingosine 1-phosphate (S1P) receptor modulator which is in phase 3 clinical trial for to treat moderate-to-severe active ulcerative colitis. The company provides Zetomipzomib, an immunoproteasome inhibitor that is in phase 2b clinical trial, for a range of immune mediated disorders, including lupus nephritis; EVER001, a covalent reversible Bruton's tyrosine kinase (BTK) inhibitor which is in the phase 1b clinical trial for the treatment of renal diseases; and mRNA platform therapeutic vaccines for cancer and autoimmune diseases. Further, it offers EVER206, a polymyxin derivative designed to treat f MDR gram negative bacterial infections reduce toxicity and nephrotoxicity which is in phase 1 of clinical trial. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
EVEREST MED.LTD DL-0001 Financial Data Overview
| 3.54 | |
| 3.54 | |
| - | |
| 3.54 | |
| 3.54 | |
| 1.65-4 | |
| 1 196 M | |
| 322 M | |
| 419 M | |
| 2.087 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
EVEREST MED.LTD DL-0001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 419 M
- EBITDA -994 985 024
- Earnings Per Share -0.42
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get EVEREST MED.LTD DL-0001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get EVEREST MED.LTD DL-0001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
